Moreover, Sallman, et al. demonstrated that mutant p53 mediates an immunosuppressive phenotype in myelodysplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML). Here, TP53 is linked to myelodysplastic syndrome.